Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease – MedPage Today

Written by

admin

in

  1. Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease  MedPage Today
  2. SGLT2 inhibitors show consistent cardio-renal protection in 70,000 patients  News-Medical
  3. Kidney Compass: SMART-C at ASN Kidney Week 2025  HCPLive

Continue Reading

More posts